Scientists test drug timing in healthy people to Fine-Tune Parkinson's treatment
NCT ID NCT07442591
Summary
This early-stage study aims to understand how the timing between doses affects how the body processes a common Parkinson's disease medication. Twelve healthy volunteers will take the drug twice a day on three separate occasions, with different hours between doses each time. The goal is to gather basic safety and timing information to help design future studies for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALHTY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Xuhui Central Hospital
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.